AMT-103 will likely not be available for all patients with HD. Credit: bangoland/Shutterstock.com. On 24 September, uniQure announced positive topline results from its pivotal Phase I/II studies ...
Bayer Latin America VP Luiz Barberini argued in favour of increased collaboration and transparency with clinical trial suppliers. Credit: Athanasios Psimadis / Arena International Events. Closer ...
The FICS platform can accelerate study conduct by 50% while ensuring audit-ready data quality. Credit: Gorodenkoff / Shutterstock.com. Pi Health has announced a partnership to deliver completely ...
atai Life Sciences and Beckley Psytech’s psychedelic has demonstrated significant efficacy in a Phase IIa trial, meaning the companies will now progress BPL-003 (intranasal mebufotenin benzoate) to ...
Tom Gottschalk, Prasun Mishra, and Luiz Barberini expounded the foundational role AI and blockchain will play in the future of clinical trials. Credit: Athanasios Psimadis/ Arena International Events ...
MBX Biosciences announced the Phase II data from the Avail trial. Image credit: Poetra.RH / Shutterstock.com MBX Biosciences is advancing its hypoparathyroidism drug after 63% of patients achieved the ...
Datavant has partnered with life sciences commercialisation firm Indegene to enhance recruitment of subjects for clinical ...
C4 Therapeutics’ zinc finger protein-1 and 3 (IKZF1/3) degrader cemsidomide has demonstrated an overall response rate (ORR) of 50% in a Phase I study in heavily pretreated patients with ...
Kairos Pharma has reported encouraging interim efficacy data from its Phase II study of ENV105 in individuals with mCRPC.
Johnson & Johnson said the combination was investigated in 49 patients with newly diagnosed multiple myeloma. Image credit: PixelBiss / Shutterstock.com Johnson & Johnson’s (J&J’s) multiple myeloma ...
The main concerns about tariffs that businesses have are higher input costs and uncertainty in long-term planning.
AstraZeneca’s Saphnelo (SC) administration has shown a decrease in disease activity in individuals with systemic lupus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback